Dentro del marco de uso exclusivamente para investigacin (RUO), es importante sealar que el Melanotan II no est aprobado como medicamento en ninguna indicacin y que su uso no supervisado se ha asociado a efectos adversos relevantes, incluyendo nuseas, rubor facial, erecciones espontneas y, de particular importancia dermatolgica, el oscurecimiento y cambio de aspecto de lunares y nevos, lo que motiva precaucin en el seguimiento de lesiones pigmentadas
NRAS and BRAF both play a part in the MAPK pathway, which are thought to contribute to melanoma development
However, to make GLP-1 analogs work well required solving two key challenges a high enough dose and making the drug last longer in our bodies i.e
Anholm C, Kumarathurai P, Pedersen LR, Samkani A, Walzem RL, Nielsen OW, et al
When compared to other antihyperglycemic agents, patients with type 2 diabetes receiving GLP-1RAs therapy exhibit a lower risk of developing colorectal cancer [45]
SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis